FDA double standards

The FDA, tasked with protecting public health, faces criticism for its double standards in regulatory enforcement. While it blocks WHO-approved pharmaceuticals from India, limiting access to affordable medications, it allows the unregulated proliferation of research chemicals like SARMs within the U.S. This selective enforcement extends to dietary supplements and food additives, posing significant risks to consumers. This article calls for accountability and meaningful reform to ensure the FDA prioritizes public health over corporate interests.